Last edition
News about "immuno-oncology"
ModeX Therapeutics Doses First Patients in Trial of Novel Tetraspecific Therapy for B-Cell Lymphoma
ModeX Therapeutics initiates clinical testing of MDX2003, a next-generation multispecific antibody therapy designed to enhance immune response and improve outcomes in B-cell lymphoma patients.
Immuno-oncology | 24/04/2026 | By News Bureau
BioMed X Launches First Research Team in France to Advance AI-Driven Antibody Design
BioMed X launches AI-focused antibody research team in France, aiming to accelerate development of next-generation biologic therapies for cancer and immune diseases.
Immuno-Oncology | 21/04/2026 | By News Bureau
The collaboration between Boehringer Ingelheim and BioNTech will evaluate a dual immuno-oncology approach in extensive-stage small cell lung cancer, aiming to improve outcomes in a disease with limited treatment options.
Immuno-oncology | 11/04/2026 | By News Bureau
Mabtech, Sai Life Sciences Partner to Expand Advanced Immunology Services in the U.S.
Mabtech and Sai Life Sciences collaborate to deploy EYRA multiplex platform in Boston, enhancing access to advanced immune profiling for biopharma and biotech research.
Immuno-oncology | 19/03/2026 | By News Bureau | 131
Zydus Launches World's First Nivolumab Biosimilar 'Tishtha' in India
Zydus Lifesciences has launched Tishtha, the world’s first biosimilar of the immunotherapy drug nivolumab, in India, aimed at expanding access to advanced cancer care by offering the treatment at nearly one-fourth the cost of the reference product for patients with multiple cancer types.
Immuno-oncology | 23/01/2026 | By News Bureau | 458
Bridge Biotherapeutics New Venture into Immuno-Oncology with University of Colorado
Bridge Biotherapeutics has forged a research collaboration with Dr. Raul Torres's Lab at the University of Colorado School of Medicine.
Immuno-oncology | 27/03/2024 | By Manvi | 507
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy